ClinicalTrials.Veeva

Menu

A Registry Study on Shenqifuzheng(a Chinese Medicine Injection)Used in Hospitals in China

C

China Academy of Chinese Medical Sciences

Status

Unknown

Conditions

Gastric Carcinoma
Carcinoma of the Lungs

Study type

Observational

Funder types

Other

Identifiers

NCT01812876
2009ZX09502-030-01

Details and patient eligibility

About

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in December 2012.

It was funded by China major scientific and technological specialized project for 'significant new formulation of new drugs'.

The purpose of this study is to make a cohort event monitoring to see whether and how Shenqifuzheng injection in hospital results in adverse events or adverse drug reactions.

Full description

It is very common that Chinese Medicine Injection used in hospitals in mainland China. However safety problems rose in recent years. There could be many uncertain factors influence Chinese Medicine Injection in clinical practice.

Safety surveillance on Chinese Medicine injection is an important problem that needs to be sorted out through large sample observational study.

A registry study for Shenqifuzheng injection safety surveillance with 30000 patients will be conducted from Jan.2013 to Dec.2014.

Eligibility criteria Patients who will use Shenqifuzheng injection in selected hospitals

Enrollment

30,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients using Shenqifuzheng injection from 2013 to 2014

Exclusion criteria

  • none

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems